MATTHEW HETTENBACH: Open Payments
NPI 1003430729 · RACINE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 6 payments from 6 companies in 2025. Trend: 2023 $935 · 2024 $652 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $109 |
| E.R. Squibb & Sons, L.L.C. | 1 | $107 |
| Teva Pharmaceuticals USA, Inc. | 1 | $97 |
| Otsuka America Pharmaceutical, Inc. | 1 | $96 |
| Neurocrine BioSciences, Inc. | 1 | $89 |
Products named: INVEGA SUSTENNA, CAPLYTA, COBENFY, AUSTEDO XR, ABILIFY MAINTENA, INGREZZA.
Industry payments across WI — which companies pay providers there.
